Matt Popkin GSK

Matt Popkin achieved a degree in Chemistry in 1995 from the University of Bristol and a PhD from University College London in 1998. Following postdoctoral research, he joined GSK to work as synthetic chemist in 2000. Since that time, he has worked in a number of roles in the CMC development and registration of novel medicines. In his current role he is Senior Director, CMC Excellence, within CMC Regulatory Affairs based in the UK, responsible for CMC Policy, Devices and vaccines facilities. Matt is vice-chair of Manufacturing and Quality Expert Group of the European Federation of Pharmaceutical Industries and Associations (EFPIA). Amongst his roles for EFPIA, he leads the CMC PRIME/COVID task force, has been a member of the ICH Q11 Implementation Working Group, and currently represents EFPIA on the ICH Quality Discussion Group.